BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Camacho V, Kuznetsova V, Welner RS. Inflammatory Cytokines Shape an Altered Immune Response During Myeloid Malignancies. Front Immunol 2021;12:772408. [PMID: 34804065 DOI: 10.3389/fimmu.2021.772408] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Selkirk E, Patel R, Hoyle A, Lie-a-ling M, Smith D, Swift J, Lacaud G. SGOL1-AS1 enhances cell survival in acute myeloid leukemia by maintaining pro-inflammatory signaling. Heliyon 2022. [DOI: 10.1016/j.heliyon.2022.e11362] [Reference Citation Analysis]
2 Klokov D, Applegate K, Badie C, Brede DA, Dekkers F, Karabulutoglu M, Le Y, Rutten EA, Lumniczky K, Gomolka M. International expert group collaboration for developing an adverse outcome pathway for radiation induced leukaemia. Int J Radiat Biol 2022;:1-24. [PMID: 36040845 DOI: 10.1080/09553002.2022.2117873] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Andina N, Bonadies N, Allam R. Inflammasome Activation in Myeloid Malignancies—Friend or Foe? Front Cell Dev Biol 2022;9:825611. [DOI: 10.3389/fcell.2021.825611] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]